Immunotherapy and the A2A Adenosine Receptor: A Confounding Brew

Clin Pharmacol Ther. 2019 Sep;106(3):498-500. doi: 10.1002/cpt.1428. Epub 2019 Apr 5.

Authors

Garth W Strohbehn¹, Mark J Ratain¹

Affiliation

¹ Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois, USA.

PMID: 30951196
DOI: 10.1002/cpt.1428

No abstract available

MeSH terms

Adenosine A2 Receptor Antagonists / pharmacology*
Caffeine / pharmacology*
Drug Therapy, Combination
Humans
Immunotherapy / methods*
Lymphocytes, Tumor-Infiltrating / drug effects
Parkinson Disease / drug therapy*
Tumor Microenvironment / drug effects

Substances

Adenosine A2 Receptor Antagonists
Caffeine